Beam Therapeutics Inc
NASDAQ:BEAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
K
|
KeyCorp
XMUN:KEY
|
US |
|
A
|
ArcelorMittal SA
F:ARRD
|
LU |
|
D
|
Diageo PLC
F:GUI
|
UK |
|
I
|
Itochu Corp
DUS:IOC
|
JP |
|
ARMOUR Residential REIT Inc
F:2AR1
|
US |
|
M3 Inc
F:4YC
|
JP |
|
A
|
Adidas AG
SWB:ADS1
|
DE |
|
Sanlorenzo SpA
MIL:SL
|
IT |
|
I
|
Intel Corp
MIL:INTC
|
US |
|
S
|
Sun Life Financial Inc
XPHS:SLF
|
CA |
|
Nextera Energy Inc
NYSE:NEE
|
US |
|
Onto Innovation Inc
NYSE:ONTO
|
US |
|
C
|
China Southern Airlines Co Ltd
XMUN:ZNHH
|
CN |
Wall St Price Targets
BEAM Price Targets Summary
Beam Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
BEAM is 51.02 USD with a low forecast of 26.26 USD and a high forecast of 84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BEAM's stock price target?
Price Target
51.02
USD
According to Wall Street analysts, the average 1-year price target for
BEAM is 51.02 USD with a low forecast of 26.26 USD and a high forecast of 84 USD.
What is the Revenue forecast for Beam Therapeutics Inc?
Projected CAGR
5%
The compound annual growth rate for Revenue over the next 3 years is 5%.